(Q33331346)
Statements
1 reference
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients (English)
1 reference
C H Takimoto
1 reference
G Morrison
1 reference
N Harold
1 reference
M Quinn
1 reference
B P Monahan
1 reference
R A Band
1 reference
J Cottrell
1 reference
A Guemei
1 reference
V Llorens
1 reference
H Hehman
1 reference
A S Ismail
1 reference
D Flemming
1 reference
D M Gosky
1 reference
H Hirota
1 reference
S J Berger
1 reference
N A Berger
1 reference
A P Chen
1 reference
J D Shapiro
1 reference
S G Arbuck
1 reference
J Wright
1 reference
J M Hamilton
1 reference
C J Allegra
1 reference
J L Grem
1 reference
1 February 2000
1 reference
1 reference
18
1 reference
659-667
1 reference
Identifiers
1 reference
1 reference